학술논문
A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncology Group study
Document Type
Article
Author
Source
In Gynecologic Oncology November 2017 147(2):283-290
Subject
Language
ISSN
0090-8258